Author

Takuya Masunaga

Kumamoto UniversityORCID 0009-0004-6511-4954Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1

Frequent Co-Authors

Mikako FujitaiD· 2 shared Adolfo SaiardiiD· 1 shared Akihiro Togami· 1 shared Andreas KaufmanniD· 1 shared Erez Y. LevanoniD· 1 shared Felix BenderiD· 1 shared Francisco Venegas SolisiD· 1 shared Henning Jacob JesseniD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMolecular Biology

Mikako FujitaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Molecular BiologybioRxivPreprintJan 18, 2026

Inositol hexakisphosphate Functions as a Cofactor and Modulator of ADAR1 Activity

Francisco Venegas Solis, Mengsi Lu, Roni Cohen‐Fultheim…·Stefan Bauer

This study shows that inositol hexakisphosphate (IP6) is an essential cofactor for ADAR1 activity, with its depletion reducing RNA editing and supplementation restoring it.

DOI 10.64898/2026.01.17.699700

humanexperimental assay

𝕏 PostBluesky

MicrobiologyJournal of Biological ChemistryPeer-reviewedAug 22, 2024

A heterocyclic compound inhibits viral release by inducing cell surface BST2/Tetherin/CD317/HM1.24

Perpetual Nyame, Akihiro Togami, Tomofumi Yoshida…·Kazuaki Monde

This paper identifies a heterocyclic compound, HT-7, that inhibits HIV-1 release by increasing cell surface BST2 expression with minimal cellular toxicity.

3 citations

humanproteomics

𝕏 PostBluesky